A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations
Clinical trial NCT07414290 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07414290
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-25
- Primary completion
- 2027-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.